Individuals With a History of Cancer Report Lower Endurance

Share this content:
Perceived fatigability and poor endurance were more commonly observed among participants who were >65 years old, researchers found.
Perceived fatigability and poor endurance were more commonly observed among participants who were >65 years old, researchers found.

(HealthDay News) -- A history of cancer is associated with fatigability and poor endurance, particularly in older adults, according to a study published recently in Cancer.

Gillian Gresham, Ph.D., from Johns Hopkins University in Baltimore, and colleagues assessed fatigability (Borg rating of perceived exertion scale after a five-minute, slow treadmill walk), endurance performance (ability and time to complete a fast-paced, 400-meter walk), and cancer history every two years among participants in the Baltimore Longitudinal Study of Aging (2007 to 2015).

The researchers found that 20 percent of participants (334 of 1,665) reported a history of cancer. Greater odds of high perceived fatigability and poor endurance were seen among participants who were >65 years old (odds ratio, 3.8) and with a history of cancer (odds ratio, 8.6; both P < 0.01). Among those who had a history of cancer, the median times to the development of high fatigability and poor endurance were shorter versus those who had no history of cancer (P < 0.01).

"The current findings suggest that a history of cancer is associated with fatigability and poor endurance and that this effect is significantly greater in older adults," the authors write. "Evaluating the effects of cancer and age on fatigability may illuminate potential pathways and targets for future interventions."

Abstract/Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs